A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant
| dc.contributor.author | El Halabi, Tarek | |
| dc.contributor.author | Dirani, Maya M. | |
| dc.contributor.author | Hotait, Mostafa | |
| dc.contributor.author | Nasreddine, Wassim M. | |
| dc.contributor.author | Beydoun, Ahmad A. | |
| dc.contributor.department | Neurology | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T12:07:40Z | |
| dc.date.available | 2025-01-24T12:07:40Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Seizure threshold-2 (SZT2) gene variants have been associated with a decrease in seizure threshold resulting in variable phenotypic expressions ranging from mild-moderate intellectual disabilities without seizures, to an early-onset epileptic encephalopathy with severe cognitive impairment. In addition, hypotonia and distinctive facial dysmorphism, including a high forehead and to a lesser extent ptosis and down-slanting palpebral fissures, were present in the majority. We herein report a novel SZT2 variant in one of two siblings both diagnosed with epilepsy of infancy with migrating focal seizures (EIMFS). This report is the fourth to document a possible familial case in EIMFS, a condition that was not previously associated with SZT2 variant. This report expands the phenotypic expression of SZT2, corroborates the importance of genetic counseling in some cases of EIMFS, and highlights the efficacy of potassium bromide in controlling the seizures associated with this condition. © 2020 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy | |
| dc.identifier.doi | https://doi.org/10.1002/epi4.12451 | |
| dc.identifier.eid | 2-s2.0-85099027320 | |
| dc.identifier.uri | http://hdl.handle.net/10938/31601 | |
| dc.language.iso | en | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.relation.ispartof | Epilepsia Open | |
| dc.source | Scopus | |
| dc.subject | Familial epilepsy of infancy with migrating focal seizures | |
| dc.subject | Infantile epileptic encephalopathy | |
| dc.subject | Potassium bromide | |
| dc.subject | Szt2 | |
| dc.subject | Biotin | |
| dc.subject | Clonazepam | |
| dc.subject | Folinic acid | |
| dc.subject | Immunoglobulin m | |
| dc.subject | Lacosamide | |
| dc.subject | Levetiracetam | |
| dc.subject | Phenobarbital | |
| dc.subject | Pyridoxine | |
| dc.subject | Valproate calcium | |
| dc.subject | Add on therapy | |
| dc.subject | Apnea | |
| dc.subject | Article | |
| dc.subject | Auditory system function | |
| dc.subject | Behavior disorder | |
| dc.subject | Blinking | |
| dc.subject | Cardiopulmonary insufficiency | |
| dc.subject | Corpus callosum | |
| dc.subject | Cyanosis | |
| dc.subject | Disease duration | |
| dc.subject | Drug dose titration | |
| dc.subject | Electroencephalography | |
| dc.subject | Epilepsy | |
| dc.subject | Face dysmorphia | |
| dc.subject | Female | |
| dc.subject | Flushing | |
| dc.subject | Focal epilepsy | |
| dc.subject | Gene | |
| dc.subject | Genetic variability | |
| dc.subject | Homozygosity | |
| dc.subject | Hypsarrhythmia | |
| dc.subject | Increased tone | |
| dc.subject | Infant | |
| dc.subject | Infantile spasm | |
| dc.subject | Lennox gastaut syndrome | |
| dc.subject | Muscle hypotonia | |
| dc.subject | Newborn | |
| dc.subject | Nuclear magnetic resonance spectroscopy | |
| dc.subject | Oxygen saturation | |
| dc.subject | Palpebral fissure | |
| dc.subject | Pregnancy | |
| dc.subject | Seizure threshold | |
| dc.subject | Sepsis | |
| dc.subject | Septum pellucidum | |
| dc.subject | Szt2 gene | |
| dc.title | A novel possible familial cause of epilepsy of infancy with migrating focal seizures related to SZT2 gene variant | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1